Evaluation of Acceptance and Commitment Therapy on glycemic control in type 2 diabetes patients

Evaluation of Acceptance and Commitment Therapy on glycemic control in type 2 diabetes patients - ACTION

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045988

Enrollment

106

Registered

2021-11-05

Start date

2021-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Receive medical treatment guidance by Acceptance and Commitment Therapy within 3 months of obtaining consent. Receive nutritional guidance at 0, 3, 6, and 9 months. Receive nutritional guidance at 0,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with type 2 diabetes Patient whose HbA1c level is 6-9% Patients who have given their written consent

Exclusion criteria

Exclusion criteria: Patient who can not speak Japanese Patient with cognitive disorder Patient who have been admitted to the hospital with diabetes within 3 months prior to the date of consent Patient who were changed in glucose-lowering drugs within 3 months prior to the date of consent Patient who participated in other interventional studies

Design outcomes

Primary

Measure	Time frame
Change in HbA1c after 6 months	—

Countries

Japan

Contacts

Public ContactHisashi Makino

National Cerebral and Cardiovascular Center Diabetes and Lipid metabolism

makinoh@ncvc.go.jp+81661701070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026